2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Sandy Srinivas: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer Docetaxel, Biosyn, Prednisone - Urologic Neoplasms, Prostate Cancer | Phase 1 | Terminated | Sandy Srinivas | 2 | 2010-04-01 | 2017-03-15 |
| Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer Temsirolimus, Casodex (bicalutamide) - Prostate Cancer, Prostatic Neoplasms | Phase 1 / Phase 2 | Terminated | Sandy Srinivas | 5 | 2009-10-01 | 2014-10-13 |
Prostatic Neoplasms (2) · Neoplasm Metastasis (1) · Urologic Neoplasms (1)
Docetaxel (1) · Prednisone (1) · bicalutamide (1) · temsirolimus (1)
United States (2)